Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the intergroup rhabdomyosarcoma studies (IRS)-II and - III

Medical and Pediatric Oncology

Volumn 33, Issue 4, 1999, Pages 362-371

  Raney, R Beverly ^a   Asmar, Lina ^b   Vassilopoulou Sellin, Rena ^a   Klein, Mary Jean ^a   Donaldson, Sarah S ^c   Green, Jennifer ^b   Heyn, Ruth ^d   Wharam, Moody ^e   Glicksman, Arvin S ^f   Gehan, Edmund A ^b   Anderson, James ^g   Maurer, Harold M ^h  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Pediat Intergroup Stat Office   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f Quality Assurance Review Center   (United States)

^g Pediat Intergroup Stat Office   (United States)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Childhood; Head neck sarcoma; Late sequelae

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; GROWTH HORMONE; HYDROCORTISONE; METHOTREXATE; THYROID HORMONE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATARACT; CHILD; FEMALE; FOLLOW UP; GROWTH INHIBITION; HEARING DISORDER; HUMAN; HYPOPLASIA; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SURVIVAL RATE; TOOTH MALFORMATION; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BEHAVIORAL SYMPTOMS; CHILD; CHILD, PRESCHOOL; FACE; FACIAL INJURIES; FEMALE; FOLLOW-UP STUDIES; GROWTH; HEAD AND NECK NEOPLASMS; HEARING DISORDERS; HUMANS; INFANT; INFANT, NEWBORN; LEARNING DISORDERS; MALE; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RHABDOMYOSARCOMA; SARCOMA; SARCOMA, EWING'S; THYROID DISEASES; TOOTH; VISION DISORDERS;

EID: 0032837234     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I     Document Type: Article

References (29)

1. Young JL Jr, Ries LG, Silverberg E, et al. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986;58:598-602.
2. Sutow WW, Lindberg RD, Gehan EA, et al. Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck: report from the Intergroup Rhabdomyosarcoma Study. Cancer 1982;49:2217-2221.
3. Wharam M, Beltangady M, Hays D, et al. Localized orbital rhabdomyosarcoma: an interim report of the Intergroup Rhabdomyosarcoma Study Committee. Ophthalmology 1987;94:251-254.
4. Raney RB Jr, Tefft M, Newton WA, et al. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1987;59:147-155.
5. Wharam MD Jr, Foulkes MA, Lawrence W Jr, et al. Soft tissue sarcoma of the head and neck in childhood: nonorbital and non-parameningeal sites. A report of the Intergroup Rhabdomyosarcoma Study (IRS)-I. Cancer 1984;53:1016-1019.
6. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I. Cancer 1988;61:209-220.
7. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-1922.
8. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-630.
9. Heyn R, Ragab A, Raney RB Jr, et al. Late effects of therapy in orbital rhabdomyosarcoma in children: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1986;57:1738-1743.
10. Shimada H, Newton WA Jr, Soule EH, et al. Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Hum Pathol 1988;19:442-453.
11. Donaldson SS, Castro JR, Wilbur JR, et al. Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy. Cancer 1973;31:26-35.
12. Haik BG, Jereb B, Smith ME, et al. Radiation and chemotherapy of parameningeal rhabdomyosarcoma involving the orbit. Ophthalmology 1986;93:1001-1009.
13. Fromm M, Littman P, Raney RB, et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck: experience at a single institution with a review of the literature. Cancer 1986;57:2070-2076.
14. Chan RC, Shukovsky LJ. Effects of irradiation on the eye. Radiology 1976;120:673-675.
15. Abramson DH, Notis CM. Visual acuity after radiation for orbital rhabdomyosarcoma. Am J Ophthalmol 1994;118:808-809.
16. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-1501.
17. Baum ES, Gaynon P, Greenberg L, et al. Phase II trial of cisplatin in refractory childhood cancer: Children's Cancer Study Group report. Cancer Treat Rep 1981;65:815-822.
18. McHaney VA, Thibadoux G, Hayes FA, et al. Hearing loss in children receiving cisplatin chemotherapy. J Pediatr 1983;102: 314-317.
19. Shalet SM, Ogilvy-Stuart AL, Crowne EC, et al. Indications for human growth hormone treatment of radiation-induced growth hormone deficiency. In: Green DM, D'Angio GJ, editors. Late effects of treatment for childhood cancer. New York: Wiley-Liss, Inc.; 1992. p 71-79.
20. Sklar CA. Neuroendocrine complications of cancer therapy. In: Schwartz CL, Hobbie WL, Constine LS, et al., editors. Survivors of childhood cancer: assessment and management. Chicago: Mosby-Year Book, Inc.; 1994. p 97-110.
21. Kao GD, Willi SM, Goldwein J. The sequellae of chemo-radiation therapy for head and neck cancer in children: managing impaired growth, development, and other side effects. Med Pediatr Oncol 1993;21:60-66.
22. Constine LS, Schwartz CL. The thyroid gland. In: Schwartz CL, Robbie WL, Constine LS, et al., editors. Survivors of childhood cancer: assessment and management. Chicago: Mosby-Year Book, Inc.; 1994. p 151-158.
23. Jaffe N, Toth BB, Hoar RE, et al. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to head and neck. Pediatrics 1984;73:816-823.
24. Kaste SC, Hopkins KP, Bowman LC. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol 1995;25:96-101.
25. Chacko DC. Considerations in the diagnosis of radiation injury. JAMA 1981;245:1255-1258.
26. Haupt R, Fears TR, Robison LL, et al. Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA 1994;272:1427-1432.
27. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 1993;11:262-270.
28. Heyn R, Khan F, Ensign LG, et al. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. Med Pediatr Oncol 1994;23:99-106.
29. Donaldson SS, Asmar L, Breneman J, et al. Hyperfractionated radiation in children with rhabdomyosarcoma - results of an Intergroup Rhabdomyosarcoma Pilot Study. Int J Radiat Oncol Biol Phys 1995;32:903-911.